Add listing
    0
    Add listing

    Cresemba (isavuconazole)

    Indicaton

    Invasive aspergillosis and mucormycosis

    Therapeutic indications
    Type of product
    Table
    • Phase
      Marketed
    • Partnering status
      Partnered
    • Partner
      Astellas for U.S.; Pfizer for Europe (excl. Nordics), China, Asia-Pacific, Israel, Russia, Turkey; Unimedic for Nordics; Asahi Kasei Pharma for Japan; Hikma for MENA region; Knight Grupo Biotoscana for Latin America; Avir for Canada
    • Available in
      U.S. and EU and several international markets

    You may also be interested in